Vycor Medical (VYCO) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,652.00 |
| Dec 31, 2025 | 5,367.00 |
| Sep 30, 2025 | 7,282.00 |
| Jun 30, 2025 | 10,670.00 |
| Mar 31, 2025 | 4,414.00 |
| Dec 31, 2024 | 6,518.00 |
| Sep 30, 2024 | 4,961.00 |
| Jun 30, 2024 | 2,922.00 |
| Mar 31, 2024 | 3,735.00 |
| Dec 31, 2023 | 7,883.00 |
| Sep 30, 2023 | 1,227.00 |
| Jun 30, 2023 | 15,171.00 |
| Mar 31, 2023 | 10,273.00 |
| Dec 31, 2022 | 9,585.00 |
| Sep 30, 2022 | 7,552.00 |
| Jun 30, 2022 | 8,800.00 |
| Mar 31, 2022 | 4,926.00 |
| Dec 31, 2021 | 7,266.00 |
| Sep 30, 2021 | 10,253.00 |
| Jun 30, 2021 | 7,781.00 |
| Mar 31, 2021 | 7,180.00 |
| Dec 31, 2020 | 8,497.00 |
| Sep 30, 2020 | 13,008.00 |
| Jun 30, 2020 | 3,838.00 |
| Mar 31, 2020 | 22,286.00 |
| Sep 30, 2019 | 31,729.00 |
| Jun 30, 2019 | 39,454.00 |
| Mar 31, 2019 | 17,346.00 |
| Dec 31, 2018 | 8,782.00 |
| Sep 30, 2018 | 12,851.00 |
| Jun 30, 2018 | 9,487.00 |
| Mar 31, 2018 | 13,082.00 |
| Dec 31, 2017 | 2,413.00 |
| Sep 30, 2017 | 20,531.00 |
| Jun 30, 2017 | 13,682.00 |
| Mar 31, 2017 | 8,939.00 |
| Dec 31, 2016 | 2,693.00 |
| Sep 30, 2016 | 29,156.00 |
| Jun 30, 2016 | 121,766.00 |
| Mar 31, 2016 | 50,128.00 |
| Dec 31, 2015 | 64,972.00 |
| Sep 30, 2015 | 28,628.00 |
| Jun 30, 2015 | 40,558.00 |